Touramanidou L, Gurung S, Cozmescu C, Perocheau D, Moulding D, Finn P
Cells. 2024; 13(23).
PMID: 39682727
PMC: 11640373.
DOI: 10.3390/cells13231979.
Shi G, Synowiec J, Singh J, Heller R
Cancer Gene Ther. 2024; 31(4):641-648.
PMID: 38337037
PMC: 11702831.
DOI: 10.1038/s41417-024-00728-0.
Merlin S, Follenzi A
Mol Ther Methods Clin Dev. 2019; 12:223-232.
PMID: 30775404
PMC: 6365353.
DOI: 10.1016/j.omtm.2018.12.013.
Annoni A, Gregori S, Naldini L, Cantore A
Cell Immunol. 2018; 342:103802.
PMID: 29735164
PMC: 6695505.
DOI: 10.1016/j.cellimm.2018.04.012.
Porada C, Rodman C, Ignacio G, Atala A, Almeida-Porada G
Front Pharmacol. 2015; 5:276.
PMID: 25566073
PMC: 4263089.
DOI: 10.3389/fphar.2014.00276.
The danger theory: 20 years later.
Pradeu T, Cooper E
Front Immunol. 2012; 3:287.
PMID: 23060876
PMC: 3443751.
DOI: 10.3389/fimmu.2012.00287.
Endothelial progenitor cell-based therapy for hemophilia A.
Matsui H
Int J Hematol. 2012; 95(2):119-24.
PMID: 22314304
DOI: 10.1007/s12185-012-1015-z.
Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy.
Jayandharan G, Aslanidi G, Martino A, Jahn S, Perrin G, Herzog R
Proc Natl Acad Sci U S A. 2011; 108(9):3743-8.
PMID: 21321191
PMC: 3048154.
DOI: 10.1073/pnas.1012753108.
Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I.
Osborn M, McElmurry R, Lees C, DeFeo A, Chen Z, Kay M
Mol Ther. 2010; 19(3):450-60.
PMID: 21081900
PMC: 3048178.
DOI: 10.1038/mt.2010.249.
Unique strategies for therapeutic gene transfer in haemophilia A and haemophilia BWFH State-of-the-Art Session on Therapeutic Gene Transfer Buenos Aires, Argentina.
Montgomery R, Monahan P, Ozelo M
Haemophilia. 2010; 16 Suppl 5:29-34.
PMID: 20590853
PMC: 5592798.
DOI: 10.1111/j.1365-2516.2010.02290.x.
Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in rats.
Markusic D, de Waart D, Seppen J
PLoS One. 2010; 5(4):e9974.
PMID: 20376311
PMC: 2848614.
DOI: 10.1371/journal.pone.0009974.
Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells.
Bharadwaj A, Kelly M, Kim D, Chao H
Blood. 2009; 115(3):500-9.
PMID: 19965663
PMC: 2810988.
DOI: 10.1182/blood-2009-08-239509.
In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance.
Annoni A, Brown B, Cantore A, Sergi Sergi L, Naldini L, Roncarolo M
Blood. 2009; 114(25):5152-61.
PMID: 19794140
PMC: 2792211.
DOI: 10.1182/blood-2009-04-214569.
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.
Brown B, Naldini L
Nat Rev Genet. 2009; 10(8):578-85.
PMID: 19609263
DOI: 10.1038/nrg2628.
Sustained viral gene delivery through core-shell fibers.
Liao I, Chen S, Liu J, Leong K
J Control Release. 2009; 139(1):48-55.
PMID: 19539680
PMC: 2747809.
DOI: 10.1016/j.jconrel.2009.06.007.
Transgene-specific host responses in cutaneous gene therapy: the role of cells expressing the transgene.
Zhang Z, Kuscu C, Ghazizadeh S
Gene Ther. 2009; 16(9):1138-45.
PMID: 19440226
PMC: 2741533.
DOI: 10.1038/gt.2009.67.
Induction of immune tolerance to FIX following muscular AAV gene transfer is AAV-dose/FIX-level dependent.
Kelly M, Zhuo J, Bharadwaj A, Chao H
Mol Ther. 2009; 17(5):857-63.
PMID: 19240690
PMC: 2835131.
DOI: 10.1038/mt.2009.25.
Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals.
Cameron J, Alexopoulou L, Sloane J, Dibernardo A, Ma Y, Kosaras B
J Neurosci. 2007; 27(47):13033-41.
PMID: 18032677
PMC: 4313565.
DOI: 10.1523/JNEUROSCI.4290-06.2007.
Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy.
Lu Z, Ghazizadeh S
Mol Ther. 2007; 15(5):954-61.
PMID: 17356544
PMC: 2877884.
DOI: 10.1038/mt.sj.6300086.
Evolving gene therapy approaches for osteosarcoma using viral vectors: review.
Witlox M, Lamfers M, Wuisman P, Curiel D, Siegal G
Bone. 2006; 40(4):797-812.
PMID: 17189720
PMC: 2731716.
DOI: 10.1016/j.bone.2006.10.017.